(5MVL) iShares Edge MSCI EM Value - Ratings and Ratios
Emerging, Value, Stocks, USD, Acc
Dividends
Currently no dividends paid| Risk via 10d forecast | |
|---|---|
| Volatility | 16.5% |
| Value at Risk 5%th | 27.3% |
| Relative Tail Risk | 0.63% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.99 |
| Alpha | 16.26 |
| CAGR/Max DD | 0.96 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.629 |
| Beta | 0.213 |
| Beta Downside | 0.493 |
| Drawdowns 3y | |
|---|---|
| Max DD | 19.15% |
| Mean DD | 2.68% |
| Median DD | 2.16% |
Description: 5MVL iShares Edge MSCI EM Value October 29, 2025
The iShares Edge MSCI EM Value Factor UCITS ETF (Acc), ticker 5MVL, is a Germany-domiciled exchange-traded fund listed on XETRA that seeks to replicate the Morningstar EM TME NR USD index, delivering an equity-only, value-tilted exposure to global emerging-market stocks.
Based on the latest fund factsheet (as of Q3 2024), the ETF carries an annual expense ratio of roughly 0.25 % and manages around €2.5 billion in assets; its sector composition is dominated by financials (≈30 % of net assets) and energy (≈15 %), reflecting the typical value bias toward dividend-paying, capital-intensive industries. The fund’s 12-month trailing dividend yield sits near 2.5 %, and its performance is closely linked to macro drivers such as emerging-market GDP growth (projected at ≈4.5 % for 2024 by the IMF) and commodity price cycles, which disproportionately affect the weighted sectors.
If you want a deeper, data-driven view of how this value-focused EM exposure fits within broader portfolio construction, a quick look at ValueRay’s analytical dashboards can provide the granular metrics you need.
What is the price of 5MVL shares?
Over the past week, the price has changed by -3.31%, over one month by -5.63%, over three months by +6.65% and over the past year by +22.13%.
Is 5MVL a buy, sell or hold?
What are the forecasts/targets for the 5MVL price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | - | - |
| Analysts Target Price | - | - |
| ValueRay Target Price | 66.7 | 13.6% |
5MVL Fundamental Data Overview December 11, 2025
Market Cap EUR = 202.3m (202.3m EUR * 1.0 EUR.EUR)
Beta = 0.0
Revenue TTM = 0.0 EUR
EBIT TTM = 0.0 EUR
EBITDA TTM = 0.0 EUR
Long Term Debt = unknown (none)
Short Term Debt = unknown (none)
Debt = unknown
Net Debt = unknown
Enterprise Value = 202.3m EUR (202.3m + (null Debt) - (null CCE))
Interest Coverage Ratio = unknown (Ebit TTM 0.0 / Interest Expense TTM 0.0)
FCF Yield = 0.0% (FCF TTM 0.0 / Enterprise Value 202.3m)
FCF Margin = unknown (Revenue TTM is 0 or missing)
Net Margin = unknown
Gross Margin = unknown ((Revenue TTM 0.0 - Cost of Revenue TTM 0.0) / Revenue TTM)
Tobins Q-Ratio = unknown (Enterprise Value 202.3m / Total Assets none)
Interest Expense / Debt = unknown (Interest Expense 0.0 / Debt none)
Taxrate = 25.0% (EU avg default 25%)
NOPAT = 0.0 (EBIT 0.0 * (1 - 25.00%))
Current Ratio = unknown (Total Current Assets none / Total Current Liabilities none)
Debt / Equity = unknown (Debt none)
Debt / EBITDA = unknown (Net Debt none / EBITDA 0.0)
Debt / FCF = unknown (Net Debt none / FCF TTM 0.0)
Total Stockholder Equity = 0.0 (from calculated bookValueOfEquity)
RoA = unknown (Net Income 0.0 / Total Assets none)
RoE = unknown (Net Income TTM 0.0 / Total Stockholder Equity 0.0)
RoCE = unknown (EBIT 0.0 / Capital Employed )
RoIC = unknown (NOPAT 0.0, Invested Capital 0.0, EBIT 0.0)
WACC = 6.80% (E(202.3m)/V(202.3m) * Re(6.80%) + (debt-free company))
Discount Rate = 6.80% (= CAPM, Blume Beta Adj.) -> floored to rf + 0.7*ERP = 8.05%
Fair Price DCF = unknown (Cash Flow 0.0)